Skip to main content
logo
Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
8,438.00
+203.00 (2.47%)
Nov 13, 2025, 5:26 PM IDT

TLV:TEVA Revenue

Teva Pharmaceutical Industries had revenue of $4.48B USD in the quarter ending September 30, 2025, with 3.42% growth. This brings the company's revenue in the last twelve months to $16.78B, up 0.02% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.

Revenue (ttm)
$16.78B
Revenue Growth
+0.02%
P/S Ratio
1.69
Revenue / Employee
$470.10K
Employees
35,686
Market Cap
94.03B ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Danel (Adir Yeoshua)2.84B
Novolog (Pharm-Up 1966)2.04B
Ilex Medical927.57M
Kamada578.74M
SofWave Medical255.13M
InterCure243.12M
BrainsWay162.56M
Bait Bakfar106.25M
Revenue Rankings

Teva Pharmaceutical Industries News

More News